Impact of gestational age on the severity of Sars-CoV-2 infection in pregnant people, in a hospital in the Buenos Aires suburbs
Abstract
continues to be established, local evidence is key to guide decision-making in clinical practice. In this way, it is important to know variables that are associated with worse evolution.
Aim: to describe the evolution of the SARS COV2 infection in pregnant people and to determine variables associated with clinical severity.
Materials and Methods: Retrospective observational cohort study. Period: 01-03-2020 to 31-07-2021. We included pregnant people with a diagnosis of COVID 19, assisted in a public maternity hospital. The cases were classified according to clinical severity based on the NIH guidelines. For the analysis, the patients were divided into 2 groups: Gropu 1: mild (ambulatory management). Group 2: moderate, severe and critical (requiring hospitalization). The relationship between variables and clinical severity was analyzed. Variables studied: Obesity, DBT, HIE, gestational age, maternal age, influenza vaccination. Newborns of infected mothers were studied with PCR for SARS -COV 2 on nasopharyngeal secretions at 24 to 48 hours after birth. Statistical analysis: Chi-square or Fisher's exact test. Significance = p <0.05. Study approved by the Institutional Ethics Committee.
Results: 52 pregnant people with a diagnosis of COVID19 were included. Median age 29.6 years. 23 patients (44%) required hospitalization and 2 (4%) MRA (mechanical respiratory assistance). 29 cases (55.5%) were mild, 19 (36.5%) moderate, 2 (4%) severe, and 2 (4%) critical. 59.6% were diagnosed with more than 28 weeks of gestation. There were no maternal or fetal deaths up to 30 days postpartum. No relationship was observed between comorbidities and clinical severity (p = 0.8). Gestational age ≥ 28 weeks was the only variable associated with more severe clinical forms, p = 0.00004. 66% of the pregnancies ended by cesarean section, which was statistically significant against the historical records of the hospital, p = 0.00004. 48/52 newborns were studied with PCR for SARS-COV 2, with only 1 (2%) being positive. This was the only symptomatic newborn.
Conclusions: In our study, SARS COV2 infection during pregnancy was associated with more severe clinical presentations, especially when the infection occurred in the 3rd trimester of pregnancy. COVID 19 was also associated with a higher incidence of termination of pregnancy by cesarean section.
Downloads
References
2. Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker AV. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochemical and biophysical research communications. 1998;245(3):933-8.
3. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American journal of obstetrics and gynecology. 2020;222(6):521-31.
4. Gujski M, Humeniuk E, Bojar I. Current State of Knowledge About SARS-CoV-2 and COVID-19 Disease in Pregnant Women. Medical science monitor : international medical journal of experimental and clinical research. 2020;26:e924725.
5. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet. 2020;395(10226):760-2.
6. Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. Journal of reproductive immunology. 2020;139:103122.
7. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020. MMWR Morbidity and mortality weekly report. 2020;69(25):769-75.
8. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. American journal of obstetrics and gynecology. 2020;222(5):415-26.
9. Zhang JP, Wang YH, Chen LN, Zhang R, Xie YF. [Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome]. Zhonghua fu chan ke za zhi. 2003;38(8):516-20.
10. Confirmación del Primer caso importado de Covid-19 en Argentina. Ministerio de Salud de la Nación. 4 de marzo 2020. https://bancos.salud.gob.ar/recurso/actualizacion-epidemiologica-confirmacion-del-primer-caso-importado-de-covid-19-en-la.
11. AISLAMIENTO SOCIAL PREVENTIVO Y OBLIGATORIO. Decreto 297/2020.DECNU-2020-297-APN-PTE - Disposiciones. 19-03-2020. https://www.boletinoficial.gob.ar/detalleAviso/primera/227042/20200320.
12. Ministerio de Salud de la Nación. Nuevo Coronavirus Covid-19. Sala de Situación Personas Gestantes y Covid-19. Información disponible al 09/08/2021. https://www.argentina.gob.ar/coronavirus/informes-diarios/sala-de-situacion/informes-especiales.
13. Ministerio de Salud de la Nación Argentina. Nuevo Coronavirus Covid-19. Recomendaciones para Equipos de Salud. Definición de Casos https://www.argentina.gob.ar/salud/coronavirus/definicion-de-caso.
14. Ministerio de Salud de la Nación Argentina. COVID-19 RECOMENDACIONES PARA LA ATENCIÓN DE EMBARAZADAS Y RECIÉN NACIDOS EN CONTEXTO DE PANDEMIA, 16 de Junio de 2021. https://bancos.salud.gob.ar/recurso/recomendaciones-para-la-atencion-de-embarazadas-y-recien-nacidos-en-contexto-de-pandemia
15. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA pediatrics. 2021;175(8):817-26.
16. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. Bmj. 2020;370:m3320.
17. Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul-Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2020;151(1):7-16.
18. San-Juan R, Barbero P, Fernandez-Ruiz M, Lopez-Medrano F, Lizasoain M, Hernandez-Jimenez P, et al. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain. EClinicalMedicine. 2020;23:100407.
19. Boushra MN, Koyfman A, Long B. COVID-19 in pregnancy and the puerperium: A review for emergency physicians. The American journal of emergency medicine. 2021;40:193-8.
20. Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: An updated systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology. 2020;252:490-501.
21. Yan J, Guo J, Fan C, Juan J, Yu X, Li J, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. American journal of obstetrics and gynecology. 2020;223(1):111 e1- e14.
22. Mahajan NN, Pophalkar M, Patil S, Yewale B, Chaaithanya IK, Mahale SD, et al. Pregnancy Outcomes and Maternal Complications During the Second Wave of Coronavirus Disease 2019 (COVID-19) in India. Obstetrics and gynecology. 2021.
23. Smithgall MC, Liu-Jarin X, Hamele-Bena D, Cimic A, Mourad M, Debelenko L, et al. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology. 2020;77(6):994-9.
24. Capobianco G, Saderi L, Aliberti S, Mondoni M, Piana A, Dessole F, et al. COVID-19 in pregnant women: A systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology. 2020;252:543-58.
25. Flaherman VJ, Afshar Y, Boscardin J, Keller RL, Mardy A, Prahl MK, et al. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.
